“South Africa Approves First AIDS Vaccine Trial”

Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

South Africa’s Medicines Control Council has approved the country’s first local AIDS vaccine test. A small phase I trial will begin within the next year in the United States, and if the vaccine is considered safe, additional studies will be conducted in South Africa and the United States. The vaccine being studied, developed by AlphaVax of North Carolina, targets the C strain of HIV, which is prevalent in southern Africa. Earlier this week, Seth Berkley, the head of the International AIDS Vaccine Initiative, said it might be 2009 before an AIDS vaccine is available.

Return to Vaccination News Home Page

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.